D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Verizon
VZ
|
+$309M |
| 2 |
AABA
Altaba Inc. Common Stock
AABA
|
+$288M |
| 3 |
TJX Companies
TJX
|
+$243M |
| 4 |
PayPal
PYPL
|
+$229M |
| 5 |
Liberty Media Series C
FWONK
|
+$219M |
Top Sells
| 1 |
McDonald's
MCD
|
+$397M |
| 2 |
Citigroup
C
|
+$328M |
| 3 |
Oracle
ORCL
|
+$221M |
| 4 |
YHOO
Yahoo Inc
YHOO
|
+$215M |
| 5 |
Netflix
NFLX
|
+$215M |
Sector Composition
| 1 | Technology | 16.75% |
| 2 | Healthcare | 14.22% |
| 3 | Consumer Discretionary | 11.66% |
| 4 | Financials | 11.15% |
| 5 | Communication Services | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
851
Accuray
ARAY
$179M
| $6.35M | 0.01% |
1,336,753
-15,132
| -1% | -$71.9K |
|
852
Elevance Health
ELV
$70.9B
| $6.35M | 0.01% |
33,746
-18,579
| -36% | -$3.5M |
|
853
Novavax
NVAX
$1.34B
| $6.34M | 0.01% |
275,482
+32,897
| +14% | +$757K |
|
854
Idexx Laboratories
IDXX
$51.6B
| $6.32M | 0.01% |
39,157
+34,862
| +812% | +$5.63M |
|
855
General Dynamics
GD
$88.7B
| $6.31M | 0.01% |
31,845
-202,836
| -86% | -$40.2M |
|
856
GSK
GSK
$83.5B
| $6.3M | 0.01% |
116,893
+22,873
| +24% | +$1.23M |
|
857
Target
TGT
$41.6B
| $6.3M | 0.01% |
120,502
-245,305
| -67% | -$12.8M |
|
|
CAI
858
DELISTED
CAI International, Inc.
CAI
| $6.29M | 0.01% |
266,637
+39,001
| +17% | +$920K |
|
859
Bausch Health
BHC
$2.68B
| $6.29M | 0.01% |
363,271
+307,640
| +553% | +$5.32M |
|
860
Option Care Health
OPCH
$4.77B
| $6.27M | 0.01% |
577,502
+97,648
| +20% | +$1.06M |
|
|
TOWR
861
DELISTED
Tower International, Inc.
TOWR
| $6.27M | 0.01% |
279,222
+41,882
| +18% | +$940K |
|
862
Ambarella
AMBA
$3.55B
| $6.25M | 0.01% |
128,813
-166,197
| -56% | -$8.07M |
|
863
Arbutus Biopharma
ABUS
$939M
| $6.24M | 0.01% |
1,734,529
-12,573
| -0.7% | -$45.3K |
|
864
Mistras Group
MG
$307M
| $6.24M | 0.01% |
284,064
-41,710
| -13% | -$916K |
|
865
Aon
AON
$80.3B
| $6.24M | 0.01% |
46,912
+40,469
| +628% | +$5.38M |
|
866
Angi Inc
ANGI
$797M
| $6.22M | 0.01% |
48,619
-6,993
| -13% | -$894K |
|
867
Xcel Energy
XEL
$43.1B
| $6.2M | 0.01% |
135,088
+126,655
| +1,502% | +$5.81M |
|
868
NMI Holdings
NMIH
$3.13B
| $6.19M | 0.01% |
540,542
-61,434
| -10% | -$703K |
|
869
Calix
CALX
$4.13B
| $6.18M | 0.01% |
902,486
-728
| -0.1% | -$4.99K |
|
870
Synovus
SNV
$7.19B
| $6.17M | 0.01% |
139,542
-40,080
| -22% | -$1.77M |
|
871
PACCAR
PCAR
$53.4B
| $6.15M | 0.01% |
139,604
+74,916
| +116% | +$3.3M |
|
872
Wolverine World Wide
WWW
$2.48B
| $6.13M | 0.01% |
218,987
+32,325
| +17% | +$905K |
|
873
Pentair
PNR
$18.5B
| $6.11M | 0.01% |
136,757
-625,160
| -82% | -$27.9M |
|
|
AFI
874
DELISTED
Armstrong Flooring, Inc.
AFI
| $6.1M | 0.01% |
339,356
-49,441
| -13% | -$888K |
|
|
AGR
875
DELISTED
Avangrid, Inc.
AGR
| $6.08M | 0.01% |
137,741
-34,266
| -20% | -$1.51M |
|